Overview of Panel Based Genetic Testing In A Consecutive Series Of Individuals

Methods: A consecutive series of individuals with clinically diagnosed IRDs without prior genetic testing underwent commercial panel-based sequencing (Invitae or Blueprint Genetics ), clinical assessment, and multimodal imaging. Retinal images were graded using the Human Phenotype Ontology terms.

Methods: A consecutive series of individuals with clinically diagnosed IRDs without prior genetic testing underwent commercial panel-based sequencing (Invitae or Blueprint Genetics ), clinical ...
Key Details About Panel Based Genetic Testing In A Consecutive Series Of Individuals

Background/Objectives: Genetic testing is important for diagnosing inherited retinal diseases (IRDs), but further evidence is needed on the utility of singleton genetic testing in an Australian cohort. Methods: A consecutive series of individuals with clinically diagnosed IRDs without prior genetic testing underwent commercial panel-based sequencing (Invitae or Blueprint Genetics ), clinical ...
Britten-Jones, A.C.; Hickey, D.G.; Edwards, T.L.; Ayton, L.N. Panel-Based Genetic Testing in a Consecutive Series of Individuals with Inherited Retinal Diseases in Australia: Identifying Predictors of a Diagnosis.

Useful Notes on Panel Based Genetic Testing In A Consecutive Series Of Individuals
Methods: A consecutive series of individuals with clinically diagnosed IRDs without prior genetic testing underwent commercial panel-based sequencing (Invitae or Blueprint Genetics ), clinical assessment, and multimodal imaging.
This case series reports the performance of a next‐generation sequencing (NGS) panel of 176 retinal genes (NGS 176) in patients with inherited retinal disease (IRD). Subjects are patients who underwent genetic testing between 1 August 2016 and 1 ...

Clinical testing with a panel of 25 genes associated with increased ...
Here we report on the outcomes of testing with a 25-gene pan-cancer panel in a consecutive series of 252,223 individuals between September 2013 and July 2016. The majority of individuals (92.8%) met testing criteria for Hereditary Breast and Ovarian Cancer (HBOC) and/or Lynch syndrome (LS).
Background Extensive clinical and genetic heterogeneity of inherited cancers has allowed multi-gene panel testing to become an efficient means for identification of patients with an inherited predisposition to a broad spectrum of syndromic and nonsyndromic forms of cancer. This study reports our experience with a 27-gene inherited cancer panel on a cohort of 630 consecutive individuals ...

Evaluation of a 27
This study reports our experience with a 27-gene inherited cancer panel on a cohort of 630 consecutive individuals referred for testing at our laboratory with the following objectives: 1.





For a gene panel to have a high clinical sensitivity, the indication for testing must have a genetic cause among a reasonably high proportion of cases. The clinical sensitivity of gene panels is primarily limited by the incompleteness of biomedical knowledge of relevant gene-disease associations, as well as a laboratory's technical ability ...